HBx protein promotes oval cell proliferation by up-regulation of cyclin D1 via activation of the MEK/ERK and PI3K/Akt pathways

International Journal of Molecular Sciences

Volumn 15, Issue 3, 2014, Pages 3507-3518

  Wang, Heng Yi ^a,b   Yang, Sheng Li ^b   Liang, Hui Fang ^b   Li, Chang Hai ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Akt; Cyclin D1; ERK; HBx; Oval cell; Proliferation

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3, 4 DIFLUOROBENZAMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; BETA ACTIN; COMPLEMENTARY DNA; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; ENHANCED GREEN FLUORESCENT PROTEIN; HEPATITIS B VIRUS X PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN P27; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; 2-(2-CHLORO-4-IODOPHENYLAMINO)-N-CYCLOPROPYLMETHOXY-3,4-DIFLUOROBENZAMIDE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; BENZAMIDE DERIVATIVE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; MORPHOLINE DERIVATIVE; TRANSACTIVATOR PROTEIN;

ADULT; ANIMAL CELL; ARTICLE; CELL COUNTING; CELL CYCLE PROGRESSION; CELL LINE; CELL PROLIFERATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DNA SEQUENCE; EXPRESSION VECTOR; GENE; GENETIC TRANSFECTION; HBX GENE; INTRACELLULAR SIGNALING; LIVER CELL; MTT ASSAY; NONHUMAN; OVAL CELL PROLIFERATION; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; RESTRICTION MAPPING; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; LIVER; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; BENZAMIDES; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; CHROMONES; CYCLIN D1; ENZYME ACTIVATION; ENZYME INHIBITORS; LIVER; MAP KINASE SIGNALING SYSTEM; MORPHOLINES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; UP-REGULATION;

EID: 84895437838     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15033507     Document Type: Article

References (34)

1. Sun, C.; Jin, X.L.; Xiao, J.C. Oval cells in hepatitis B virus-positive and hepatitis C virus-positive liver cirrhosis: Histological and ultrastructural study. Histopathology 2006, 48, 546-555.
2. Conigliaro, A.; Brenner, D.A.; Kisseleva, T. Hepatic progenitors for liver disease: Current position. Stem Cells Cloning 2010, 3, 39-47.
3. Eleazar, J.A.; Memeo, L.; Jhang, J.S.; Mansukhani, M.M.; Chin, S.; Park, S.M.; Lefkowitch, J.H.; Bhagat, G. Progenitor cell expansion: An important source of hepatocyte regeneration in chronic hepatitis. J. Hepatol. 2004, 41, 983-991.
4. Fotiadu, A.; Tzioufa, V.; Vrettou, E.; Koufogiannis, D.; Papadimitriou, C.S.; Hytiroglou, P. Progenitor cell activation in chronic viralhepatitis. Liver Int. 2004, 24, 268-274.
5. Lowes, K.N.; Brennan, B.A.; Yeoh, G.C.; Olynyk, J.K. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am. J. Pathol. 1999, 154, 537-541.
6. Knight, B.; Yeoh, G.C.; Husk, K.L.; Ly, T.; Abraham, L.J.; Yu, C.; Rhim, J.A.; Fausto, N. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exp. Med. 2000, 192, 1809-1818.
7. Lowes, K.N.; Croager, E.J.; Olynyk, J.K.; Abraham, L.J.; Yeoh, G.C. Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J. Gastroenterol. Hepatol. 2003, 18, 4-12.
8. Knight, B.; Matthews, V.B.; Akhurst, B.; Croager, E.J.; Klinken, E.; Abraham, L.J.; Olynyk, J.K.; Yeoh, G. Liver inflammation and cytokine production, but not acute phase protein synthesis, accompany the adult liver progenitor (oval) cell response to chronic liver injury. Immunol. Cell Biol. 2005, 83, 364-374.
9. Brooling, J.T.; Campbell, J.S.; Mitchell, C.; Yeoh, G.C.; Fausto, N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. Hepatology 2005, 41, 906-915.
10. Nguyen, L.N.; Furuya, M.H.; Wolfraim, L.A.; Nguyen, A.P.; Holdren, M.S.; Campbell, J.S.; Knight, B.; Yeoh, G.C.; Fausto, N.; Parks, W.T. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology 2007, 45, 31-41.
11. Hwang, G.Y.; Lin, C.Y.; Huang, L.M.; Wang, Y.H.; Wang, J.C.; Hsu, C.T.; Yang, S.S.; Wu, C.C. Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J. Clin. Microbiol. 2003, 41, 5598-5603.
12. Cheng, A.S.; Chan, H.L.; Leung, W.K.; To, K.F.; Go, M.Y.; Chan, J.Y.; Liew, C.T.; Sung, J.J. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: Implication of HBx in upregulation of COX-2. Modern Pathol. 2004, 17, 1169-1179.
13. Zhou, Y.M.; Cao, L.; Li, B.; Zhang, X.Z.; Yin, Z.F. Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinoma. Hepatobiliary Pancreat. Dis. Int. 2012, 11, 532-535.
14. Hsia, C.C.; Thorgeirsson, S.S.; Tabor, E. Expression of hepatitis B surface and core antigens and transforming growth factor-alpha in "oval cells" of the liver in patients with hepatocellular carcinoma. J. Med. Virol. 1994, 43, 216-221.
15. Watanabe, M.; Umenai, T.; Ohori, H.; Ishida, N. Evidence for the multiplication of hepatitis B virus in "oval cell" culture originated from human embryonic liver. Br. J. Exp. Pathol. 1976, 57, 211-216.
16. Chung, T.W.; Lee, Y.C.; Kim, C.H. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: Involvement of invasive potential. FASEB J. 2004, 18, 1123-1125.
17. Tang, R.X.; Kong, F.Y.; Fan, B.F.; Liu, X.M.; You, H.J.; Zhang, P.; Zheng, K.Y. HBx activates FasL and mediates HepG2 cell apoptosis through MLK3-MKK7-JNKs signal module. World J. Gastroenterol. 2012, 18, 1485-1495.
18. Park, Y.H.; Shin, H.J.; Kim, S.U.; Kim, J.M.; Kim, J.H.; Bang, D.H.; Chang, K.T.; Kim, B.Y.; Yu, D.Y. iNOS promotes HBx-induced hepatocellular carcinoma via upregulation of JNK activation. Biochem. Biophys. Res. Commun. 2013, 435, 244-249.
19. Sze, K.M.; Chu, G.K.; Lee, J.M.; Ng, I.O. C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. Hepatology 2013, 57, 131-139.
20. Neuzillet, C.; Hammel, P.; Tijeras-Raballand, A.; Couvelard, A.; Raymond, E. Targeting the Ras-ERK pathway in pancreatic adenocarcinoma. Cancer Metastasis Rev. 2013, 32, 147-162.
21. Dent, P. Crosstalk between ERK, AKT, and cell survival. Cancer Biol. Ther. 2014, 15, doi:10.4161/cbt.27311.
22. Pal, I.; Mandal, M. PI3K and Akt as molecular targets for cancer therapy: Current clinical outcomes. Acta Pharmacol. Sin. 2012, 33, 1441-1458.
23. Li, C.H.; Wang, Y.J.; Dong, W.; Xiang, S.; Liang, H.F.; Wang, H.Y.; Dong, H.H.; Chen, L.; Chen, X.P. Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo. Cancer Lett. 2011, 311, 1-10.
24. Shan, C.; Xu, F.; Zhang, S.; You, J.; You, X.; Qiu, L.; Zheng, J.; Ye, L.; Zhang, X. Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2. Cell Res. 2010, 20, 563-575.
25. Qiao, L.; Leach, K.; McKinstry, R.; Gilfor, D.; Yacoub, A.; Park, J.S.; Grant, S.; Hylemon, P.B.; Fisher, P.B.; Dent, P. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression. Hepatology 2001, 34, 906-917.
26. Walker, J.L.; Assoian, R.K. Integrin-dependent signal transduction regulating cyclin D1 expression and G1 phase cell cycle progression. Cancer Metastasis Rev. 2005, 24, 383-393.
27. Tashiro, E.; Tsuchiya, A.; Imoto, M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci. 2007, 98, 629-635.
28. Jun, E.K.; Zhang, Q.; Yoon, B.S.; Moon, J.H.; Lee, G.; Park, G.; Kang, P.J.; Lee, J.H.; Kim, A.; You, S. Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-beta/SMAD2 and PI3K/Akt pathways. Int. J. Mol. Sci. 2013, 15, 605-628.
29. Yokota, J.; Chosa, N.; Sawada, S.; Okubo, N.; Takahashi, N.; Hasegawa, T.; Kondo, H.; Ishisaki, A. PDGF-induced PI3K-mediated signaling enhances the TGFbetainduced osteogenic differentiation of human mesenchymal stem cells in a TGF-beta-activated MEK-dependent manner. Int. J. Mol. Med. 2014, 33, 534-542.
30. Jo, C.; Koh, Y.H. Cadmium induces N-cadherin cleavage via ERK-mediated gamma-secretase activation in C6 astroglia cells. Toxicol. Lett. 2013, 222, 117-121.
31. Sakamoto, T.; Ozaki, K.; Fujio, K.; Kajikawa, S.H.; Uesato, S.; Watanabe, K.; Tanimura, S.; Koji, T.; Kohno, M. Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models. Biochem. Biophys. Res. Commun. 2013, 433, 456-462.
32. Park, S.G.; Chung, C.; Kang, H.; Kim, J.Y.; Jung, G. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter. J. Biol. Chem. 2006, 281, 31770-31777.
33. Lazaro, C.A.; Rhim, J.A.; Yamada, Y.; Fausto, N. Generation of hepatocytes from oval cell precursors in culture. Cancer Res. 1998, 58, 5514-5522.
34. Yang, S.; Pan, X.; Xiong, Z.; Wei, B.; Yao, H. The influence of hepatitis B virus X protein on the clock genes in liver cells and its significance. Chin.-Ger. J. Clin. Oncol. 2011, 10, 468-471.